Assessment of Patient-Led or Physician-Driven Continuous Glucose Monitoring in Patients

With Poorly Controlled Type 1 Diabetes Using Basal-Bolus Insulin Regimens

Featured Article:

Jean-Pierre Riveline, M.D., Pauline Schaepelynck, M.D., Lucy Chaillous, M.D., Ph.D., Eric Renard, M.D., Ph.D., Agnès Sola-Gazagnes, M.D., Alfred

Penfornis, M.D., Ph.D., Nadia Tubiana-Rufi, M.D., Véronique Sulmont, M.D., Bogdan Catargi, M.D., Ph.D., Céline Lukas, M.D., Régis P. Radermecker, M.D., Charles Thivolet, M.D., Ph.D., François Moreau, M.D., Pierre-Yves

Benhamou, M.D., Ph.D., Bruno Guerci, M.D., Ph.D., Anne-Marie Leguerrier, M.D., Luc Millot, M.D., Claude Sachon, M.D., Guillaume Charpentier, M.D.,

Hélène Hanaire, M.D., For The EVADIAC Sensor Study Goup

Diabetes Care Volume 35: 965-971

May, 2012

Study Objectives

• The benefits of real-time continuous glucose monitoring (CGM) have been demonstrated in patients with type 1 diabetes

• Aim was to compare the effect of two modes of use of CGM, patient-led or physician-driven, in subjects with poorly controlled type 1 diabetes

Riveline J et al. Diabetes Care 2012;35:965-971

Study Design

• 197 patients with type 1 diabetes aged 8–60 years with HbA1c > 8% randomly assigned to:

• Patient-led CGM• Physician-driven CGM• Conventional self-monitoring of blood glucose

• Glucose control outcomes assessed at 1 year

Riveline J et al. Diabetes Care 2012;35:965-971

Riveline J et al. Diabetes Care 2012;35:965-971

Riveline J et al. Diabetes Care 2012;35:965-971

Riveline J et al. Diabetes Care 2012;35:965-971

Conclusions

• Both patient-led and physician-driven CGM provide similar long-term improvement in glucose control in patients with poorly controlled type 1 diabetes

• Physician-driven CGM mode used fewer sensors. 

Riveline J et al. Diabetes Care 2012;35:965-971